Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 5,776–5,800 of 7,816 matching trials · page 232 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Pilot Study to Examine Health Effects of Daylight Exposure on Dementia Patients NCT03483896 Daylight Intervention Runs in: United States · 8 sites |
NA other |
COMPLETED | 83 | University of Southern California OTHER |
2019-03-29 |
|
Study to Examine the Safety and Efficacy of Pimavanserin for the Treatment of Agitation and Aggression in Alzheimer's Disease (SERENE) NCT02992132 Pimavanserin 34 mg; Pimavanserin 20 mg; Placebo Runs in: Chile; France; Spain; United Kingdom; United States · 56 sites |
PHASE2 other |
TERMINATED | 111 | ACADIA Pharmaceuticals Inc. INDUSTRY |
2019-03-28 |
|
Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder NCT02871427 Nelotanserin Runs in: United States · 19 sites |
PHASE2 other |
TERMINATED | 80 | Axovant Sciences Ltd. INDUSTRY |
2019-03-27 |
|
Multi-parameter Diagnostic Blood Test for the Diagnosis of Alzheimer's Disease NCT02409030 Runs in: Belgium; France; Spain · 16 sites |
NA other |
COMPLETED | 700 | Raman Health Technologies, S.L. INDUSTRY |
2019-03-26 |
|
Phase 0 Evaluation of [18F]MNI-958 as a Potential PET Radioligand for Imaging Tau Protein in the Brain NCT03058965 [18F]MNI-958; [18F]Florbetapir; DaTscan Runs in: United States · 1 site |
EARLY_PHASE1 other |
COMPLETED | 12 | Molecular NeuroImaging OTHER |
2019-03-25 |
|
Circle Dance for Family Caregivers of the Elderly With Alzheimer. NCT03081533 Circle Dance Program (CircleCare) Runs in: Brazil · 1 site |
NA other |
UNKNOWN | 40 | Universidade Federal de Sao Carlos OTHER |
2019-03-25 |
|
Tailored Activity Program-Veterans Affairs NCT01357564 Tailored Activity Program; Attention Control Runs in: United States · 1 site |
NA other |
COMPLETED | 322 | VA Office of Research and Development OTHER_GOV |
2019-03-22 |
|
Touchscreen Technology and Art for People With Dementia in Care Homes NCT03773016 Art apps Runs in: United Kingdom · 1 site |
NA other |
UNKNOWN | 12 | University of Nottingham OTHER |
2019-03-22 |
|
Computerized Cognitive Training for MCI NCT03232047 Combined executive function and memory training Runs in: China · 1 site |
NA other |
UNKNOWN | 120 | Peking University OTHER |
2019-03-21 |
|
Montessori Intervention for Individuals With Dementia: A Feasibility Study From Pakistan NCT03491774 Montessori Intervention Runs in: Pakistan · 1 site |
NA other |
COMPLETED | 24 | Pakistan Institute of Living and Learning OTHER |
2019-03-21 |
|
The Brain Ketone Body Challenge Imaging Study NCT03204604 Challenge A - low calorie Ensure®; Challenge B - Ensure® plus keton... Runs in: United States · 1 site |
NA other |
WITHDRAWN | 0 | Wake Forest University Health Sciences OTHER |
2019-03-19 |
|
Evaluation of [123I] MNI-187 and SPECT in Patients With Alzheimers Disease in Comparison to Healthy Subjects NCT00456417 123-I MNI-187 Injection and Imaging Procedures Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 30 | Institute for Neurodegenerative Disorders OTHER |
2019-03-14 |
|
Evaluation of [123I] AV51 and SPECT as a Marker of Beta-amyloid Protein Deposition in Subjects With Alzheimer Disease in Comparison to Healthy Subjects NCT00556660 [123I] AV-151 Runs in: United States · 2 sites |
PHASE1 other |
COMPLETED | 20 | Institute for Neurodegenerative Disorders OTHER |
2019-03-14 |
|
Comparison of Once Daily and Twice Daily Dosing on Safety and Tolerability of Memantine in Patients With Alzheimer NCT02553928 Memantine (once daily); Memantine (twice daily) Runs in: China · 6 sites |
PHASE4 symptomatic-cholinergic |
COMPLETED | 62 | H. Lundbeck A/S INDUSTRY |
2019-03-14 |
|
Cognitive Intervention for Persons With Amnestic Mild Cognitive Impairment NCT02785315 rehabilitation & remediation approach; remediation approach Runs in: Taiwan · 1 site |
NA other |
COMPLETED | 40 | National Taiwan University Hospital OTHER |
2019-03-14 |
|
Gerontology Research Programme: The Singapore Longitudinal Ageing Studies (SLAS I & II) NCT03405675 SLAS 1; SLAS 2 Runs in: Singapore · 1 site |
NA other |
UNKNOWN | 6,183 | National University of Singapore OTHER |
2019-03-14 |
|
Effects of Muscle Relaxation on Cognitive Function in Patients With Mild Cognitive Impairment and Early Stage Dementia. NCT03507192 Muscle relaxation using full body massage machine Runs in: South Korea · 1 site |
NA other |
UNKNOWN | 60 | Samsung Medical Center OTHER |
2019-03-14 |
|
Korea Alzheimer's Disease Neuroimaging Initiative NCT01979419 Runs in: South Korea · 1 site |
NA other |
UNKNOWN | 500 | Korean Alzheimers' Disease Neuroimaing Intitiative OTHER |
2019-03-08 |
|
Mild Cognitive Impairment and Obstructive Sleep Apnea NCT01482351 CPAP adherence intervention; Attention control intervention Runs in: United States · 3 sites |
NA other |
COMPLETED | 54 | George Mason University OTHER |
2019-03-06 |
|
Evaluating Simvastatin's Potential Role in Therapy NCT00486044 Simvastatin; Placebo Runs in: United States · 1 site |
PHASE2 other |
COMPLETED | 103 | University of Wisconsin, Madison OTHER |
2019-03-05 |
|
PET Imaging Study Using [11C]PIB in Subjects With AD & Healthy Volunteers NCT01826110 [11C]PIB Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 21 | Johns Hopkins University OTHER |
2019-03-05 |
|
A Dose Titration Study of CPC-201 in Patients With Dementia of Alzheimer's Type NCT02549196 Donepezil; Solifenacin Runs in: United States · 4 sites |
PHASE2 symptomatic-cholinergic |
COMPLETED | 28 | Chase Pharmaceuticals Corporation, an affiliate of Allergan plc INDUSTRY |
2019-03-05 |
|
Photobiomodulation & Ketogenic Diet for Treatment of Mid-periphery Retinal Disorders for Alzheimer's Disease Prevention NCT03859245 Photobiomodulation; Ketogenic diet Runs in: United States · 1 site |
NA other |
UNKNOWN | 30 | Bristlecone Health, Inc. INDUSTRY |
2019-03-04 |
|
Enhancing Working Memory in Patients With Early Alzheimer's Disease Through the Use of rTMS NCT02537496 Repetitive Transcranial Magnetic Stimulation; Repetitive Transcrani... Runs in: Canada · 1 site |
NA other |
COMPLETED | 36 | Centre for Addiction and Mental Health OTHER |
2019-02-28 |
|
pCO2 Oscillations During Exercise: Relation to Cerebral Blood Flow and to Cognitive Dysfunction in COPD NCT02660437 Pulmonary Rehabilitation program Runs in: Germany · 1 site |
NA other |
COMPLETED | 91 | Schön Klinik Berchtesgadener Land OTHER |
2019-02-28 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial